OS Therapies OSTX
NYSE OSTX
$1.30 +0.04 (+3.18%)
As of: Oct 21, 2026 · 11:41 AM EDT

OS Therapies (OSTX) Notes Payables (2023 - 2026)

Updated

OS Therapies (OSTX) recorded Notes Payables of $1.34 million in Q1 2026.

Analysis

OS Therapies (OSTX) Notes Payables (2023 - 2026) Analysis & Trends

At the end of FY2023, OS Therapies reported Notes Payables of $2.03 million.

  • The Q1 2026 figure is the highest quarterly Notes Payables since Q1 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn
10 OS Therapies 6.21 Mn 2.94 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 1.34 Mn
Jun 30, 2024 250,000.00
Mar 31, 2024 2.28 Mn
Dec 31, 2023 2.03 Mn
API Access

OS Therapies Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=OSTX&period=max&api_key=YOUR_API_KEY